Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men

NCT01200862 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese Hypogonadotropic Hypogonadism

Interventions

DRUG: Investigational new drug company code: BGS649
DRUG: Placebo

Sponsor

Mereo BioPharma

Collaborators

[object Object]